Crossmark

Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors

Crossref DOI link: https://doi.org/10.1186/s13065-022-00852-8

Published Online: 2022-08-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beniwal, Meenu

Jain, Neelam

Jain, Sandeep

Aggarwal, Navidha
License Information

Text and Data Mining valid from 2022-08-17

Version of Record valid from 2022-08-17
More Information

Article History

Received: 30 April 2022

Accepted: 26 July 2022

First Online: 17 August 2022

Declarations

:

: The authors declare that there is no conflict of interest regarding the publication of this paper.

Document is current

Any future updates will be listed below